rs281865025
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PM2PP3_ModeratePP5_Very_Strong
The NM_024312.5(GNPTAB):c.771G>A(p.Leu257Leu) variant causes a splice region, synonymous change. The variant allele was found at a frequency of 0.000013 in 1,612,570 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_024312.5 splice_region, synonymous
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 12 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GNPTAB | NM_024312.5 | c.771G>A | p.Leu257Leu | splice_region_variant, synonymous_variant | Exon 7 of 21 | ENST00000299314.12 | NP_077288.2 | |
GNPTAB | XM_011538731.3 | c.690G>A | p.Leu230Leu | splice_region_variant, synonymous_variant | Exon 7 of 21 | XP_011537033.1 | ||
GNPTAB | XM_006719593.4 | c.771G>A | p.Leu257Leu | splice_region_variant, synonymous_variant | Exon 7 of 19 | XP_006719656.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GNPTAB | ENST00000299314.12 | c.771G>A | p.Leu257Leu | splice_region_variant, synonymous_variant | Exon 7 of 21 | 1 | NM_024312.5 | ENSP00000299314.7 | ||
GNPTAB | ENST00000549940.5 | c.771G>A | p.Leu257Leu | splice_region_variant, synonymous_variant | Exon 7 of 11 | 1 | ENSP00000449150.1 | |||
GNPTAB | ENST00000552681.1 | c.405G>A | p.Leu135Leu | synonymous_variant | Exon 3 of 3 | 1 | ENSP00000449217.1 | |||
RNA5SP368 | ENST00000364298.1 | n.*223C>T | downstream_gene_variant | 6 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152148Hom.: 0 Cov.: 32
GnomAD4 exome AF: 0.0000123 AC: 18AN: 1460422Hom.: 0 Cov.: 30 AF XY: 0.0000124 AC XY: 9AN XY: 726664
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152148Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74318
ClinVar
Submissions by phenotype
Pseudo-Hurler polydystrophy Pathogenic:1
- -
Pseudo-Hurler polydystrophy;C2673377:Mucolipidosis type II Pathogenic:1
This sequence change affects codon 257 of the GNPTAB mRNA. It is a 'silent' change, meaning that it does not change the encoded amino acid sequence of the GNPTAB protein. RNA analysis indicates that this variant induces altered splicing and likely results in a shortened protein product. This variant is not present in population databases (gnomAD no frequency). This variant has been observed in individual(s) with mucolipidosis type III (PMID: 15633164). ClinVar contains an entry for this variant (Variation ID: 2761). Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Studies have shown that this variant results in skipping of exon 7, but is expected to preserve the integrity of the reading-frame (PMID: 15633164). In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. -
Mucolipidosis III alpha/beta, atypical Pathogenic:1
- -
Mucolipidosis Pathogenic:1
Variant summary: GNPTAB c.771G>A (p.Leu257Leu) alters a conserved nucleotide located close to a canonical splice site and therefore could affect mRNA splicing, leading to a significantly altered protein sequence. Several computational tools predict a significant impact on normal splicing: Three predict the variant weakens a 5' donor site and one predicts the variant abolishes a 5' splicing donor site. Experimental evidence supports these predictions indicating that this variant affects mRNA splicing leading to the skipping of exon 7 (Steet_2005). The variant was absent in 251190 control chromosomes (gnomAD). c.771G>A has been reported in the literature in a homozygous individual affected with Mucolipidosis (Steet_2005). These data indicate that the variant may be associated with disease. Experimental evidence evaluating an impact on protein function demonstrated the variant results in the production of a minimal amount of functional enzyme (Steet_2005). A ClinVar submitter (evaluation after 2014) cites the variant as likely pathogenic. Based on the evidence outlined above, the variant was classified as likely pathogenic. -
Mucolipidosis type II Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at